STAT+: FTC settles lawsuit with CVS Caremark over charges it manipulated insulin prices, impeded access

AI Summary

The FTC has settled a lawsuit with CVS Caremark over allegations of insulin price manipulation and restricted access to diabetes treatment. The settlement addresses major concerns in healthcare pricing and access in the United States.

The FTC settled a lawsuit against CVS Caremark over allegations that the company artificially inflated the price of insulin and impeded access to the diabetes treatment.